$PBIO New to The Street Signs Pressure BioSciences, Inc. To 12 Month TV Series, Agreement Includes Commercials and Billboard Ads
https://www.globenewswire.com/news-release/20...d-Ads.html
NEW YORK, June 01, 2023 (GLOBE NEWSWIRE) -- FMW Media's business TV show, New to The Street, announces the signing of a 12-month contract for filming and broadcasting tailored interviews and commercials about Pressure BioSciences, Inc. (OTCQB: PBIO) ($PBIO).
New to The Street’s TV anchors will interview the management team at PBIO with each show airing on New to The Street's televised syndicated outlets on Newsmax and Fox Business Network, sponsored program on Bloomberg TV, and website www.newtothestreet.com.
Pressure BioSciences, Inc. develops and sells innovative extreme pressure-based platform technology solutions for the global life sciences industry. The Company generates revenues from its patented platforms: Pressure Cycling Technology (“PCT™”), BaroFold™ Platform, and Ultra Shear Technology (“UltraShear™” or “UST™”).
With over 300 PCT installations worldwide, their Who’s Who of blue-chip customers spanning industry, academia and government are using PBIO products for vaccine developments, soil/plant biology applications, biotherapeutics, and diverse other life sciences applications. A wide array of scientific key opinion leaders underpins their credibility as their new UltraShear technology launches a new era of delivering oil-based nutrients and therapeutics, invisibly solubilized as nanoemulsions of oil in water.
The New to The Street’s social media team and television network partners will re-share media content, creating a platform to increase awareness about PBIO. All broadcasted shows will stream on the New to The Street website, www.newtothestreet.com. On a schedule, show previews and commercial ads will air on selected New to The Street syndicated and sponsored TV platforms. Digital ads will stream on New to The Street's billboard platform throughout New York City.
Richard T. Schumacher, President/CEO of Pressure BioSciences, Inc., states, “I look forward to appearing on New to The Street, to share our Company’s business success stories with viewers. PBIO commercializes its patented technologies to create and deploy products that are uniquely transformative in their markets. We are particularly excited about our UltraShear platform, now poised for explosive growth as a game-changer to the basis of competition across multiple diverse major markets. During each show, the objective will be to inform viewers about the Company growth strategies, current/ future products, and expected opportunities.”
TV viewers will hear about more about PBIO’s patented technologies, from PCT using alternating cycles of hydrostatic pressures to control biomolecular interactions and facilitate unprecedented scientific outcomes, to BaroFold controlling the critical refolding of proteins into active configurations for biopharmaceuticals, to UltraShear’s breakthroughs in speed and completeness of payload delivery across pharmaceuticals, nutraceuticals, cosmeceuticals, food/beverages, agrochem and other markets. Their platforms are gaining worldwide recognition, with customers daily increasing usage of their products from biomarker discovery to biopharmaceutical production to revolutions in treatment, nutrition, health and beauty.
Vince Caruso, CEO / Producer of New to The Street, states, "I am excited in having PBIO on the show for a 12-part TV series. They have patents, products, and a dedicated team that I believe our viewers will enjoy learning more about. With recognized scientific peer-reviewed publications about the Company’s products, and worldwide sales, the Company is positioned for a strong growth trajectory. The PBIO storyline is compelling, and I'm excited for the New to The Street audience to learn more about the Company."
New to The Street's TV interviews with Pressure BioSciences, Inc.’s management, airing on Newsmax (syndicated), Fox Business Network (syndicated), and Bloomberg TV (sponsored) "To Be Announced."
https://www.globenewswire.com/news-release/20...d-Ads.html
NEW YORK, June 01, 2023 (GLOBE NEWSWIRE) -- FMW Media's business TV show, New to The Street, announces the signing of a 12-month contract for filming and broadcasting tailored interviews and commercials about Pressure BioSciences, Inc. (OTCQB: PBIO) ($PBIO).
New to The Street’s TV anchors will interview the management team at PBIO with each show airing on New to The Street's televised syndicated outlets on Newsmax and Fox Business Network, sponsored program on Bloomberg TV, and website www.newtothestreet.com.
Pressure BioSciences, Inc. develops and sells innovative extreme pressure-based platform technology solutions for the global life sciences industry. The Company generates revenues from its patented platforms: Pressure Cycling Technology (“PCT™”), BaroFold™ Platform, and Ultra Shear Technology (“UltraShear™” or “UST™”).
With over 300 PCT installations worldwide, their Who’s Who of blue-chip customers spanning industry, academia and government are using PBIO products for vaccine developments, soil/plant biology applications, biotherapeutics, and diverse other life sciences applications. A wide array of scientific key opinion leaders underpins their credibility as their new UltraShear technology launches a new era of delivering oil-based nutrients and therapeutics, invisibly solubilized as nanoemulsions of oil in water.
The New to The Street’s social media team and television network partners will re-share media content, creating a platform to increase awareness about PBIO. All broadcasted shows will stream on the New to The Street website, www.newtothestreet.com. On a schedule, show previews and commercial ads will air on selected New to The Street syndicated and sponsored TV platforms. Digital ads will stream on New to The Street's billboard platform throughout New York City.
Richard T. Schumacher, President/CEO of Pressure BioSciences, Inc., states, “I look forward to appearing on New to The Street, to share our Company’s business success stories with viewers. PBIO commercializes its patented technologies to create and deploy products that are uniquely transformative in their markets. We are particularly excited about our UltraShear platform, now poised for explosive growth as a game-changer to the basis of competition across multiple diverse major markets. During each show, the objective will be to inform viewers about the Company growth strategies, current/ future products, and expected opportunities.”
TV viewers will hear about more about PBIO’s patented technologies, from PCT using alternating cycles of hydrostatic pressures to control biomolecular interactions and facilitate unprecedented scientific outcomes, to BaroFold controlling the critical refolding of proteins into active configurations for biopharmaceuticals, to UltraShear’s breakthroughs in speed and completeness of payload delivery across pharmaceuticals, nutraceuticals, cosmeceuticals, food/beverages, agrochem and other markets. Their platforms are gaining worldwide recognition, with customers daily increasing usage of their products from biomarker discovery to biopharmaceutical production to revolutions in treatment, nutrition, health and beauty.
Vince Caruso, CEO / Producer of New to The Street, states, "I am excited in having PBIO on the show for a 12-part TV series. They have patents, products, and a dedicated team that I believe our viewers will enjoy learning more about. With recognized scientific peer-reviewed publications about the Company’s products, and worldwide sales, the Company is positioned for a strong growth trajectory. The PBIO storyline is compelling, and I'm excited for the New to The Street audience to learn more about the Company."
New to The Street's TV interviews with Pressure BioSciences, Inc.’s management, airing on Newsmax (syndicated), Fox Business Network (syndicated), and Bloomberg TV (sponsored) "To Be Announced."
